doi: 10.1186/s12951-024-02930-6, 133
Pair these medications with a proactive strategy maybe even better, one that is informed by your DNA
Patients for whom the extended-release formulation offers genuine clinical benefit better tolerability, improved adherence, reduced side effects will continue to be prescribed it, and insurers will cover it for those indications
By understanding how the activity and secretion of these molecules can lead to metabolic diseases it may be possible to identify new and more efficient treatments, offering alternative paths for more effective therapies
In this article, we'll take a closer look at what each platform offers, comparing their medications, program features, and overall philosophies
References: Nauck M, Frid A, Hermansen K, et al